DoW Peer Reviewed Cancer, Idea Award
About
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to Service Members, Veterans, other military beneficiaries and the American public. Distinctive Features: The proposed project should demonstrate creative thinking and innovation. • Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award. • Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale. • New for FY26: Early Career Investigator Option: The Early Career Investigator option is designed to support the continued development of promising independent investigators that are early in their faculty appointments.
The DoW Peer Reviewed Cancer, Idea Award is a prestigious federal grant program designed to support innovative, high-risk/potentially high-reward cancer research concepts that advance knowledge in patient care and treatment options within the Military Health System. This program is ideal for cancer researchers, academic institutions, and research organizations seeking to pursue creative, untested ideas and paradigms that go beyond incremental advances. The award supports basic cancer research that benefits Service Members, Veterans, military beneficiaries, and the broader American public. Unlike traditional grant programs, the Idea Award specifically encourages innovative thinking and does not require preliminary data—only strong scientific rationale is necessary. A distinctive feature new for FY26 is the Early Career Investigator Option, which supports promising independent researchers early in their faculty appointments. Researchers should apply if they have groundbreaking cancer research concepts that represent a significant departure from established approaches. This program is perfect for those who want to pursue bold, transformative research ideas that could reshape cancer treatment and care within military and veteran populations.
Funding Facts
● Applications openDeadline
October 5, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-10-05
Grant Type
federal
Application Cycle
Annual
Best For
Cancer researchers, academic institutions, research organizations, early-career faculty with innovative, high-risk cancer research concepts
Frequently Asked Questions
Who is eligible for DoW Peer Reviewed Cancer, Idea Award?
Specific eligibility criteria are not detailed in the available information. However, the program supports cancer researchers and institutions conducting research relevant to the Military Health System. The FY26 cycle includes an Early Career Investigator Option for promising independent researchers early in their faculty appointments. For complete and current eligibility requirements, visit the official Department of Defense or program website.
How much funding does DoW Peer Reviewed Cancer, Idea Award provide?
Specific funding amounts are not specified in the available information. Award amounts may vary by cycle and research proposal scope. Contact the official program office or visit the Department of Defense website for current funding levels and budget guidelines for FY26 and beyond.
How do I apply for DoW Peer Reviewed Cancer, Idea Award?
The application process details are not provided in the available information. Applicants should consult the official Department of Defense Peer Reviewed Cancer Research Program (PRCRP) website for current application procedures, submission deadlines, required documentation, and specific guidelines. The FY26 deadline is October 5, 2026. Direct inquiries to the official program office for the most accurate application instructions.
What can DoW Peer Reviewed Cancer, Idea Award funding be used for?
Funding supports innovative, untested, high-risk/potentially high-reward cancer research concepts, theories, paradigms, and basic cancer research. Projects should demonstrate creative thinking and innovation that advances knowledge in cancer research, patient care, or treatment options within the Military Health System. The program specifically does not fund incremental advances or logical next steps in existing research models. Strong scientific rationale is required, though preliminary data is not mandatory.
Last updated: July 5, 2026